Viewing Study NCT01018069


Ignite Creation Date: 2025-12-24 @ 10:50 PM
Ignite Modification Date: 2025-12-25 @ 8:19 PM
Study NCT ID: NCT01018069
Status: TERMINATED
Last Update Posted: 2011-07-13
First Post: 2009-11-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: AEG35156 in Combination With High-dose Cytarabine and Idarubicin in AML Following Failure of a Single Standard Dose Cytarabine Based Frontline Induction Regimen
Sponsor: Aegera Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module